Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Becker Muscular Dystrophy
NCT01350154Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Nov 2011
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP-001 in Becker muscular dystrophy (BMD), sponsored by Rigshospitalet. Started Nov 2011; status: completed.
02
Drugs
ASP-001
03
Conditions
Becker muscular dystrophy (BMD)
Beyond the preview
Go deeper on NCT01350154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01350154.